NCT00053781View on ClinicalTrials.gov

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 20, 2003

Primary Completion Date

September 14, 2004

Study Completion Date

December 21, 2009

Conditions
Melanoma (Skin)
Interventions
DRUG

perifosine

Trial Locations (6)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

B3H 1V7

Nova Scotia Cancer Centre, Halifax

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

M5G 2M9

Princess Margaret Hospital at University Health Network, Toronto

H2L-4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

H2W 1S6

McGill University, Montreal

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NCIC Clinical Trials Group

NETWORK